Study of ARO-ANG3 in Adults With Mixed Dyslipidemia
Trial details
- Registry ID
- NCT04832971
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ARO-ANG3 in Adults With Mixed DyslipidemiaNCT04832971 | Arrowhead Pharmaceuticals | Phase 2 | Completed | 2022-08-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |